Saturday 17 October 2026 Export TXMD’s income statement to Excel — free account

TherapeuticsMD, Inc.

TXMD Healthcare Drug Manufacturers Specialty & Generic

TherapeuticsMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 million, up 71.6% from fiscal 2024. In the quarter to June 2026, revenue fell 8.72%, EPS fell 80.0% and free cash flow grew 104.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.90 0.03 −1.55%

Follow TXMD

Alert me

Market cap: $22.3M
P/E: 0.0×
Fwd P/E: 18.9×
Dividend yield: —
F-score: 6/9
Altman Z: −34.36
Beneish M: −2.54
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	49.32	0.00	121.69	0.00
P/S ratio Full definition →		4.47	6.24	6.97	7.82
P/FCF ratio Full definition →		7.27	9.07	10.06	9.40
P/Operating CF Full definition →		12.51	50.29	24.77	32.84
P/B ratio Full definition →		0.46	0.70	0.87	0.94
Price to Tangible BV Full definition →		0.53	0.82	1.00	1.09
EV/Sales Full definition →		96.83	91.57	83.60	86.16
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		129.16	112.76	103.85	90.97
EV/FCF Full definition →		157.40	133.16	120.66	103.54
Quick Ratio Full definition →		2.18	2.30	2.37	2.52
Current Ratio Full definition →		2.93	3.02	3.11	3.22
Net Debt/EBITDA Full definition →		9.29	11.58	21.15	9.65
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.07	0.08	0.09	0.09
Operating CF/Net income Full definition →		6.57	(0.61)	9.94	5.03
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Interest Coverage Full definition →		(287.33)	—	—	—
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		193.62%	256.66%	186.88%	181.47%
Intangible Assets out of Total Assets Full definition →		0.10	0.10	0.10	0.09
Share Based Compensation of Revenue Full definition →		0.00%	5.71%	0.28%	0.46%
Graham Net Nets Full definition →		0.26	0.19	0.20	0.22
Graham Number Full definition →		1.08	0.00	0.93	0.00
Earnings Yield Full definition →		2.03%	(3.28%)	0.82%	(1.06%)
Free Cash Flow Yield Full definition →		13.76%	11.02%	9.94%	10.64%
Revenue per Share Full definition →		0.07	0.08	0.06	0.08
Operating CF per Share Full definition →		0.09	0.03	0.08	0.07
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.09	0.03	0.08	0.07
Cash per Share Full definition →		0.61	0.65	0.73	0.79
Shareholders Equity per Share Full definition →		2.37	2.32	2.33	2.34
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.37	2.32	2.33	2.34
Free Cash Flow Full definition →		1.00	0.38	0.94	0.78
Working Capital Full definition →		9.56	9.66	10.35	11.12
Net Current Asset Value Full definition →		3.28	3.67	4.66	5.72
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		3.49	3.54	3.10	3.57
Average Payables Full definition →		0.25	0.32	0.10	0.41
Average Assets Full definition →		39.11	38.24	37.91	38.02
Average Common Equity Full definition →		27.27	27.12	26.86	27.21

Show all line items

Columns are period end dates

Stockrow Weekly